We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DocuSign (DOCU) to Report Q3 Earnings: What's in the Offing?
Read MoreHide Full Article
DocuSign, Inc. (DOCU - Free Report) is scheduled to report third-quarter fiscal 2021 results on Dec 3, after the bell.
The company has an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate in all of the last four quarters, delivering an average earnings surprise of 139.7%.
Expectations This Time Around
The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $360.4 million, indicating 44.4% year-over-year growth. Continued strength in eSignature solutions is expected to have driven the top line. In the second quarter of fiscal 2021, the company’s revenues of $342.2 million climbed 45.2% year over year.
The consensus mark for non-GAAP earnings is pegged at 12 cents, suggesting 9.1% jump from the year-ago quarter. Improving operating leverage is likely to have boosted the bottom line. In the second quarter of fiscal 2021, non-GAAP earnings of 17 cents per share surged more than 100% year over year.
What Our Model Says
Our proven Zacks model does not conclusively predict an earnings beat for DocuSign this season. The combination of a positive Earnings ESP, and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
DocuSign has an Earnings ESP of 0.00% and carries a Zacks Rank #3.
Equifax (EFX - Free Report) reported better-than-expected second-quarter 2020 adjusted earnings of $1.60 per share, which beat the Zacks Consensus Estimate by 22.1% and improved 14.3% on a year-over-year basis.
IQVIA Holdings (IQV - Free Report) reported second-quarter 2020 adjusted earnings per share of $1.18, which beat the consensus mark by 12.4% but fell 22.9% on a year-over-year basis.
Robert Half (RHI - Free Report) reported second-quarter 2020 earnings of 41 cents per share beat the consensus mark by 17% but were down 58% year over year.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
DocuSign (DOCU) to Report Q3 Earnings: What's in the Offing?
DocuSign, Inc. (DOCU - Free Report) is scheduled to report third-quarter fiscal 2021 results on Dec 3, after the bell.
The company has an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate in all of the last four quarters, delivering an average earnings surprise of 139.7%.
Expectations This Time Around
The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $360.4 million, indicating 44.4% year-over-year growth. Continued strength in eSignature solutions is expected to have driven the top line. In the second quarter of fiscal 2021, the company’s revenues of $342.2 million climbed 45.2% year over year.
The consensus mark for non-GAAP earnings is pegged at 12 cents, suggesting 9.1% jump from the year-ago quarter. Improving operating leverage is likely to have boosted the bottom line. In the second quarter of fiscal 2021, non-GAAP earnings of 17 cents per share surged more than 100% year over year.
What Our Model Says
Our proven Zacks model does not conclusively predict an earnings beat for DocuSign this season. The combination of a positive Earnings ESP, and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
DocuSign has an Earnings ESP of 0.00% and carries a Zacks Rank #3.
You can see the complete list of today’s Zacks #1 Rank stocks here.
DocuSign Inc. Price and EPS Surprise
DocuSign Inc. price-eps-surprise | DocuSign Inc. Quote
Performance of Other Business Services Companies
Equifax (EFX - Free Report) reported better-than-expected second-quarter 2020 adjusted earnings of $1.60 per share, which beat the Zacks Consensus Estimate by 22.1% and improved 14.3% on a year-over-year basis.
IQVIA Holdings (IQV - Free Report) reported second-quarter 2020 adjusted earnings per share of $1.18, which beat the consensus mark by 12.4% but fell 22.9% on a year-over-year basis.
Robert Half (RHI - Free Report) reported second-quarter 2020 earnings of 41 cents per share beat the consensus mark by 17% but were down 58% year over year.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>